Brought to you by 
Autimmune Technologies licenses test from Tulane University
04 Jun 1999
Executive Summary
Autoimmune Technologies was founded to commercialize a test developed by Robert F. Garry, PhD of the Tulane University Medical School. The test links silicone breast implants to an autoimmune disease characterized by the presence of an antibody.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Chemistry, Immunoassay
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Autimmune Technologies licenses test from Tulane University
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice